MedCity News
Read about news from Turing, ChromaCode, NeuroFlow and more.
Shares0
ChromaCode has been named a finalist in the XPRIZE Rapid Covid Testing Competition, which aims to increase testing capabilities & accelerate the development of high-quality testing that is low cost, easy to use & quick reporting.
Turing is pleased to announce that it is expanding its Board of Directors, adding Ashu Garg, General Partner at Foundation Capital, and Sumir Chadha, Co-founder and Managing Director at WestBridge Capital. The move comes after Turing’s recent announcement of its $32 million Series B funding round led by WestBridge Capital, which has a $3.3 billion fund, and including Foundation Capital, which led Turing’s earlier round. To date, Turing has raised nearly $50 million in venture funding.